Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Union Budget
Budget 2011-2012 Home
Industry Expectations - Budget 2011-2012
Industry Reactions - Budget 2011-2012
Budget 2010-2011
Budget 2010-2011 Home
Industry Expectations - Budget 2010-2011
Industry Reactions - Budget 2010-2011
Contributor's Corner
Bonanza Portfolio
Hemant K Gupta
Krish Bhatt
S A A R T H I
Trinity Investments
Exchange Information
BSE 2009 Holidays
NSE 2009 Holidays
Investor Guide
Depository & Dematerialisation
Grievance Redressal
Investor Guide
SEBI
Trading of Securities
Transfer of Securities
Your Rights
Budget 2009-2010
Budget 2009-2010 Home
Industry Expectations - Budget 2009-2010
Industry Reactions - Budget 2009-2010
Interim Budget 2009-2010 Home
Industry Expectations - Interim Budget 2009
Budget 2008-2009
Railway Budget 2008-2009
Industry Expectations - Budget 2008
Union Budget 2008-2009
Highlights of Budget 2008-2009
Summary of Budget 2008-2009
Industry Reactions - Budget 2008
IPOs
Current IPOs
Past IPOs
IPO Subscription
Mutual Funds
Gold Exchange Traded Fund
MF Unique Holding
Forthcoming Dividends
ELSS Schemes Comparison
Tax Plans
New Fund Offers
Research
Arbitrages
Equity
Market Whispers
Tax Planning
Home
Equity Linked Savings Scheme
Post Office MIS
9% GOI Senior Citizens Savings Scheme
8% Savings (Taxable) Bonds
Kisan Vikas Patra
National Savings Certificate
Public Provident Fund
Research

| More

HDFC Limited - Steady performance continues - Antique

Posted On: 2013-05-10 01:35:17

HDFC Limited demonstrated one more quarter of strong performance with reported earnings at INR 15.5bn; substantially above our estimates of INR 14.1bn (consensus estimates at INR 14.8bn) on back of strong traction in NII income. Continued buoyancy in loan growth, strong operating efficiency and pristine asset quality were the key positives that emerged from the results.

Valuation & Outlook

At the CMP of INR 886, HDFC is trading at 4.3x FY15e P/BV and 21.1x FY15e P/E which continues to remain tad expensive given the near term challenges. Therefore, we maintain our HOLD recommendation on the stock with a target price of INR 840/share and roll over our earnings estimates to FY15e.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Power Finance Corporation - Cheap valuations factor in concerns - Angel Broking
Federal Bank - Q1FY16 Result Update - Sushil Finance
Bajaj Auto - 1QFY2016 Result Update - Angel Broking
Crompton Greaves - 1QFY2016 Result Update - Angel Broking
Rallis India - 1QFY2016 Result Update - Angel Broking
Views on Maruti Suzuki 1QFY2016 Results: Angel Broking
India Auto: Tyre Segment - Revving up: AnandRathi Research
Views on Ambuja Cement 2QCY2015 Results: Angel Broking
Views on Tech Mahindra 1QFY2016 Results: Angel Broking
Views on TVS Motors 1QFY2016 Results: Angel Broking
India Infrastructure - Reforms signal all systems go! - Religare
Views on Lupin - Updates: Angel Broking
Views on Wipro 1QFY2016 Results: Angel Broking
View on Lupin Limited 1QFY2016 Results: Angel Broking
Views on Bajaj Auto 1QFY2016 Results: Angel Broking
Views on Ceat Ltd 1QFY2016 Results: Angel Broking
View on Sanofi India 2QCY2015 Results: Angel Broking
Views on Eicher Motors 2QCY2015 Results: Angel Broking
Views on HDFC Bank 1QFY2016 Results: Angel Broking
Views on Sun Pharmaceuticals Update: Angel Broking
Views on Infosys 1QFY2016 Results: Angel Broking
Views on Rane Brake Liners 1QFY2016 Results: Angel Broking
Views on Ultratech Cement 1QFY2015 Results: Angel Broking
Views on Lupin - get USFDA approval for Prandimet: Angel Broking
Views on NPPA - Update: Angel Broking
BUY Unichem Laboratories: Anand Rathi Research
Views on Hindustan Media Ventures Ltd 1QFY2016 Results: Angel Broking
Views on Sun Pharmaceuticals: Angel Broking
Views on Dr. Reddys announces the Launch of Memantine Hydrochloride Tablets: Angel Broking
JM Financial buy reccomendation on Shriram Transport Finance Company
Styrolution ABS (India) - Company Update - Angel Broking
KNR Constructions - Road laid for a sustainable drive - Angel Broking
Views on Wipro Digital to Enhance Digital Transformation Capability with Designit: Angel Broking
Views on TCS 1QFY2016 Results: Angel Broking
Views on Tech Mahindra inks strategic pact with PNMsoft: Angel Broking
Views on Infosys signs multi-year agreement with Deutsche Bank: Angel Broking
India Auto sales in June 2015 - Microsec
Alembic Pharma, Lupin & Sun Pharma get approval for Desvenlafaxine Succinate: Angel Broking
Views on Zydus Cadila receives Market Authorisation (MA) from USFDA for Morphine Sulfate ER Tablets: Angel Broking
India Economy Core infrastructure - Sharp recovery in core, may not be sustainable - Anand Rathi Financial Services
Views on Tech Mahindra - Investor Update: Angel Broking
BUY Welspun India - Anand Rathi Retail Research
BUY Persistent Systems - Anand Rathi Research
Alembic Pharmaceuticals - Gets tentative approval from USFDA for Celecoxib: Angel Broking
Views on Tech Mahindra and Circle Health sign 10-year strategic deal: Angel Broking
World financial fears keep Asia firms in holding pattern
India Technology - Tapering growth and volatility weighing on valuations: Anand Rathi Financial Services
Views on Lupin - Board of Directors approve the Fund Raising: Angel Broking
Views on NPPA update: Angel Broking
Views on Aurobindo Pharma gets USFDA approval for Azithromycin: Angel Broking


  
Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2014